SARS-COV-2 – a major risk factor for pulmonary embolism, a retrospective observational study from a single tertiary care hospital

ABSTRACT

P46 Table 1Incidence of pe by gender and covid status COVID POSITIVE (309) COVID NEGATIVE (621) TOTAL (930) PE 41 (13.3%) 95 (15.3%) 136 (14.6%) Male 28 (9.1%) 52 (8.4%) 80(8.6%) Female 13(4.2%) 43 (6.9%) 56(6.0%) No PE 268 (86.7%) 526(84.7%) 794 (85.4%) Male 161 (52.1%) 218(35.1%) 379 (40.8%) Female 107 (34.6%) 308(49.6%) 415(44.6%) Total 309 (100%) 621 (100%) 930(100%) ConclusionCovid-19 has been identified as a significant risk factor for PE. These patients must be anti-coagulated in order to avoid various complications, including life-threatening arrhythmias, severe hypoxemia, shock, even death.ReferencesJevnikar M, et al. Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission. European Respiratory Journal 2021 Jul 1;58(1).Katsoularis I, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19 nationwide self-controlled cases series and matched cohort study. BMJ 2022 Apr 6;377.